Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1994 1
1997 1
1999 1
2001 1
2002 1
2006 1
2007 1
2008 2
2009 1
2010 1
2011 3
2013 1
2015 3
2016 3
2017 2
2018 4
2019 4
2020 4
2021 3
2022 6
2023 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Harker-Murray P, Mauz-Körholz C, Leblanc T, Mascarin M, Michel G, Cooper S, Beishuizen A, Leger KJ, Amoroso L, Buffardi S, Rigaud C, Hoppe BS, Lisano J, Francis S, Sacchi M, Cole PD, Drachtman RA, Kelly KM, Daw S. Harker-Murray P, et al. Among authors: buffardi s. Blood. 2023 Apr 27;141(17):2075-2084. doi: 10.1182/blood.2022017118. Blood. 2023. PMID: 36564047 Free PMC article. Clinical Trial.
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Daw S, Cole PD, Hoppe BS, Hodgson D, Beishuizen A, Garnier N, Buffardi S, Mascarin M, Lissat A, Mauz-Körholz C, Krajewski J, Akyol A, Crowe R, Anderson B, Xu Y, Drachtman RA, Kelly KM, Leblanc T, Harker-Murray P. Daw S, et al. Among authors: buffardi s. JAMA Oncol. 2025 Mar 1;11(3):249-257. doi: 10.1001/jamaoncol.2024.5627. JAMA Oncol. 2025. PMID: 39745739 Clinical Trial.
HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.
De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M. De Re V, et al. Among authors: buffardi s. Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285306 Free PMC article.
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M. Massano D, et al. Among authors: buffardi s. Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2. Pediatr Blood Cancer. 2022. PMID: 35656841
Comparison of Hodgkin's Lymphoma in Children and Adolescents. A Twenty Year Experience with MH'96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols.
Burnelli R, Fiumana G, Rondelli R, Pillon M, Sala A, Garaventa A, D'Amore ESG, Sabattini E, Buffardi S, Bianchi M, Vinti L, Zecca M, Muggeo P, Provenzi M, Farruggia P, Rossi F, D'Amico S, Facchini E, Bernasconi S, De Santis R, Casini T, Porta F, D'Alba I, Mura R, Verzegnassi F, Sau A, Cesaro S, Perruccio K, Cellini M, Bertolini P, Sperlì D, Pericoli R, Galimberti D, Civino A, Mascarin M. Burnelli R, et al. Among authors: buffardi s. Cancers (Basel). 2020 Jun 18;12(6):1620. doi: 10.3390/cancers12061620. Cancers (Basel). 2020. PMID: 32570974 Free PMC article.
The prognostic value of biological markers in paediatric Hodgkin lymphoma.
Farruggia P, Puccio G, Sala A, Todesco A, Buffardi S, Garaventa A, Bottigliero G, Bianchi M, Zecca M, Locatelli F, Pession A, Pillon M, Favre C, D'Amico S, Provenzi M, Trizzino A, Zanazzo GA, Sau A, Santoro N, Murgia G, Casini T, Mascarin M, Burnelli R; AIEOP Italian Association of Pediatric Hematology and Oncology and Hodgkin Lymphoma Working Group. Farruggia P, et al. Among authors: buffardi s. Eur J Cancer. 2016 Jan;52:33-40. doi: 10.1016/j.ejca.2015.09.003. Epub 2015 Nov 27. Eur J Cancer. 2016. PMID: 26630532
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease.
Lopci E, Burnelli R, Guerra L, Cistaro A, Piccardo A, Zucchetta P, Derenzini E, Todesco A, Garaventa A, Schumacher F, Farruggia P, Buffardi S, Sala A, Casale F, Indolfi P, Biondi S, Pession A, Fanti S. Lopci E, et al. Among authors: buffardi s. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1620-7. doi: 10.1007/s00259-011-1836-7. Epub 2011 May 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21559977
44 results